Check back at 8:30 a.m. ET for results
DUBLIN, October 13, 2021–(BUSINESS WIRE)–The "Global Baby Oral Care (Toothbrush & Toothpaste) Market Outlook, 2026" report has been added to ResearchAndMarkets.com's offering.
The baby oral care market is evaluated to be more than USD 1300 Million in the year 2020.
To achieve clarity, the market has been studied from different facets by appropriately segmenting the market. The baby oral care market has been broadly segmented into 2 product segmentations- baby toothbrushes and baby toothpaste. Further different sales and distribution channels have been analyzed by categorizing them into hypermarket/supermarket sales, pharmacy/drugstore, convenience stores, and online sales channels.
Big personal care brands, as well as smaller baby consumer-centric companies, are positioning themselves to capture the rapidly growing baby oral care market, especially in the developing regions and markets. These products are available in different variants like toothpaste with the mild formula of natural and herbal ingredients and toothbrushes with soft and gentle bristles.
The rise in disposable income, changing lifestyle and rising awareness about early childhood caries is to enhance the market of baby oral care in the coming period. The marketers are coming with more innovations in oral products such as cavity protection pastes, flavored toothpaste, cartoon character-based toothbrush, etc.
Parents are now more concerned about the oral care disease, as the baby's immune system is more sensitive and it is proven that certain oral disorders can be fatal. Of the two major product types- Toothpaste & Toothbrush, the market share is distributed almost at an even pace across them. However, the market is led by the toothpaste segment which is expected to reach nearly 60% of the market share by the end of the forecasted period.
On further evaluation, it was observed that the Asia Pacific region holds the largest share globally, with its largest population of babies in the world. What makes the Asia-Pacific markets for baby oral care lucrative are not just the suitable demographic trends in the region, but also the fact that the region is home to some of the fastest-growing economies in the world.
The Asia Pacific has a much lesser penetration rate of baby oral care products as compared to developed North America and European markets. However, different regions have different adoption and penetration rates when it comes to baby oral care. Parents use their traditional techniques of maintaining babies' hygiene.
Parents in the west are more adaptive and open to new products whereas parents in Middle Eastern countries stick to more traditional approaches. Many doctors and healthcare professionals suggest that parents should be using a soft, wet towel, wrapping it around the finger to clean the baby's teeth and gums.
Sales channels that are used for sales and distribution of baby oral care products also differ from region to region. In North America and Europe, the primary sales channels driving the sales of oral care products are the supermarkets/hypermarkets. In Asia Pacific markets, supermarkets/hypermarkets do have a significant share among other channels, but convenience stores shares look much more prominent in Asia than in North America and Europe.
Online sale channel solves the problem of communicating essential information related to the product and health care of the baby. However, the online sales channels are growing at a CAGR of 12.01% in the Asia Pacific region which is much higher than the growth rate in the North America and European market.
A personal experience in buying a baby product is fundamental for the fact that parents find it more assuring as they can clear doubts and get better confidence in the quality and standard of products they are buying. One trend which is common in both developing and developed markets in the baby oral care trend is the online sales channels.
Key Topics Covered:
1. Executive Summary
2. Report Methodology
3. Market Structure
3.1. Market Considerate
3.2. Market Definitions
4. Global Baby Oral Care Market Outlook
4.1. Market Size by Value
4.2. Market Share
4.2.1. By Sales Channel
4.2.2. By Region
4.2.3. By Country
5. North America Baby Oral Care Market Outlook
5.1. Market Size by Value
5.2. Market Share
5.2.1. By Sales Channel
5.2.2. By Country
5.2.3. By Product
5.3. US Baby Oral Care Market
5.4. Canada Baby Oral Care Market
5.5. Mexico Baby Oral Care Market
6. Europe Baby Oral Care Market Outlook
7. Asia Pacific Baby Oral Care Market Outlook
8. Latin America Baby Oral Care Market Outlook
9. Middle East & Africa Baby Oral Care Market Outlook
10. Market Dynamics
10.1. Key Drivers
10.2. Key Challenges
11. Market Trends and Developments
12. Company Profiles
12.1. Artsana S.p.A
12.2. Colgate-Palmolive Company
12.3. Henkel AG & Co. KGaA
12.4. Johnson & Johnson Private Limited
12.5. Procter & Gamble
For more information about this report visit https://www.researchandmarkets.com/r/snf9r1
View source version on businesswire.com: https://www.businesswire.com/news/home/20211013005828/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
'The Big Short' guy remains bearish. But he's long on this trio of stocks.
Bank of America reported its third-quarter 2021 financial results today. The news release, supplemental filing and investor presentation can be accessed at Bank of America's Investor Relations website at https://investor.bankofamerica.com/quarterly-earnings.
Novavax (NASDAQ: NVAX) has taken investors on a wild roller-coaster ride so far this year. After all of these dizzying gyrations, Novavax appears to be the biggest bargain among the top vaccine stocks. Here's why Novavax stock is absurdly cheap right now.
Shares of AT&T Inc. dropped 0.6% in afternoon trading Wednesday, putting them on track to suffer the longest losing streak in a year, and as they headed for the lowest close since July 2010. The stock has shed 7.5% over the past six sessions, which would be the longest stretch of losses since the nine-day loss streak that ended Oct. 21, 2020. The selloff has boosted AT&T's implied dividend yield to 8.23%, making it the second-highest yielding stock in the S 500 , just below fellow communications
Taiwan Semiconductor Manufacturing, the world's largest chip foundry, on Thursday beat expectations for third-quarter earnings.
Plug Power has had some tailwinds that have helped to make it more attractive to investors of late.
Late last month, Pfizer (NYSE: PFE) announced that its drug, abrocitinib, was approved by Japan's Ministry of Health, Labour and Welfare (MHLW) as a treatment for patients 12 years old and up with moderate to severe atopic dermatitis or eczema. Japan's regulatory approval of abrocitinib under its trade name of Cibinqo came just weeks after approval by the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) for adults and adolescents with moderate to severe eczema. Let's dig into why the MHLW approved the drug for its eczema indication, as well as its sales potential and what it means for Pfizer.
Is AbbVie stock a buy as shares make a comeback on promising news for its drugs, Skyrizi and Rinvoq, in inflammatory conditions?
Specifically, Roku and Palantir should benefit from unstoppable trends in the coming years, and, with both stocks currently trading at a discount, now looks like a good time to add a few shares to your portfolio. Palantir specializes in big data. Since then, Palantir has won contracts with numerous government organizations, including the U.S. Air Force, Army, and the U.S. Coast Guard, as well as the National Nuclear Security Administration and the U.S. Department of Health and Human Services.
In this article, we discuss the 11 best Robinhood stocks to buy according to hedge funds. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Robinhood Stocks To Buy According To Hedge Funds. Equity trading applications have become more famous as the rapid digitization of the world […]
The COVID-19 pandemic disrupted nearly every industry in some way, with it hitting the aerospace sector especially hard. If no one is flying, companies won’t want to continue ordering and paying for new airplanes. Boeing (BA) was already in a precarious position with its 737 MAX saga, but the company has been emerging from its slump and is poised for potential upside. (See Analyst Top Stocks on TipRanks) One analyst on the bullish side of the fence is Sheila Kahyaoglu of Jefferies Group, who wro
Yahoo Finance’s Jared Blikre reports on the day's trending tickers.
Canadian-based cannabis company Sundial Growers (NASDAQ: SNDL) has been busy this year. The latest move came this month when it announced the purchase of retail company Alcanna (OTC: LQSIF), which operates 171 liquor stores in Canada (most of which are in Alberta — Sundial's home province). This move further diversifies Sundial's existing operations and gives it yet another source of revenue.
Bank of America said Thursday its third-quarter earnings rose to $7.7 billion, or 85 cents a share, from $4.9 billion, or 51 cents a share, in the year-ago period. Revenue increased to $22.8 billion from $20.3 billion. Net interest income rose 10% to $11.1 billion. The bank released $1.1 billion in reserves to its bottom line, driven primarily by asset quality improvements. A survey of analysts by FactSet estimated earnings of 71 cents a share on revenue of $21.68 billion and net interest income
Analysts were split Wednesday as they compared Crispr's gene-edited cancer drug to Allogene's — but CRSP stock tumbled as ALLO stock popped.
Worried about inflation? You should be — especially if you own the wrong assets and bet against S&P 500 and growth stocks.
UnitedHealth earnings beat Q3 estimates and the health care giant raised guidance. UNH stock, a Dow Jones component, rose in early action.
Toymaker Hasbro Inc said on Tuesday longtime Chairman and Chief Executive Officer Brian Goldner has died, two days after he went on medical leave. In a statement last year, Goldner said he had been under continued medical treatment following his cancer diagnosis in 2014. Board member and former CEO of marketing firm InnerWorkings Inc, Rich Stoddart, has replaced Goldner on an interim basis.
Summer has wound down, the Q3 earnings reports will be coming in over the next few weeks, and every investor can see that the market is hitting a rolling boil. For investors in search of a bright spot, Canaccord Chief Market Strategist Tony Dwyer believes the increasing volatility in the market could lead to attractive entry points. "Our core fundamental thesis remains positive, our tactical indicators coupled with history suggest any further weakness should prove temporary, and we expect the ye
When the financial media mentions "tech stocks," many people equate the term with consumer hardware or business software. After all, those are the companies that get talked about the most, so they're what many of us are most familiar with. For that, you need to find the companies that are behind the scenes.